Spots Global Cancer Trial Database for liver disease
Every month we try and update this database with for liver disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | NCT02074202 | Hepatocellular ... Liver Disease | 18F- fluorochol... 18F- fluorodeox... | 20 Years - 80 Years | National Taiwan University Hospital | |
| Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease | NCT00543777 | Liver Cancer | Magnetic Resona... 2-Point Dixon M... | - | M.D. Anderson Cancer Center | |
| Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction | NCT00006062 | Liver Disease | oxaliplatin | - | National Institutes of Health Clinical Center (CC) | |
| Orthotopic Liver Transplantation Using a Living Donor | NCT00152607 | Liver Disease Liver Neoplasms | donor right hep... | 18 Years - 55 Years | University of Chicago | |
| A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma | NCT02508467 | Hepatocellular ... | Fisogatinib (BL... | 18 Years - | Blueprint Medicines Corporation | |
| Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma | NCT01390194 | Underlying Live... Hepatitis Fibrosis of Liv... Cirrhosis With ... Lesion on a Pri... | 19 Years - | University of Nebraska | ||
| Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy | NCT00627042 | Hepatocellular ... | Ramucirumab (IM... | 18 Years - | Eli Lilly and Company | |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma | NCT02989870 | HepatoCellular ... Unresectable He... Liver Cancer | Stereotactic Bo... Sorafenib Bavituximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma | NCT02508467 | Hepatocellular ... | Fisogatinib (BL... | 18 Years - | Blueprint Medicines Corporation | |
| A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) | NCT03289533 | Carcinoma, Hepa... | Avelumab (MSB00... Axitinib (AG-01... | 20 Years - | Pfizer | |
| A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) | NCT03289533 | Carcinoma, Hepa... | Avelumab (MSB00... Axitinib (AG-01... | 20 Years - | Pfizer | |
| Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese | NCT04185454 | Heathy Women Pre Menopausal ... Exlution Criter... Liver Disease Diabetes Cancer Kidney Disorder | Jarlsberg chees... | 20 Years - | Meddoc | |
| Therasphere for Unresectable Primary or Secondary Liver Neoplasia | NCT02960620 | Liver Cancer Liver Neoplasms HepatoCellular ... | TheraSphere Tre... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems | NCT03814005 | Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... Renal Insuffici... Liver Disease Neoplasms | Azacitidine Pevonedistat Docetaxel Paclitaxel Carboplatin | 18 Years - | Takeda | |
| Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese | NCT04185454 | Heathy Women Pre Menopausal ... Exlution Criter... Liver Disease Diabetes Cancer Kidney Disorder | Jarlsberg chees... | 20 Years - | Meddoc | |
| An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 | NCT01316679 | Hepatocellular ... Liver Disease | 18 Years - 90 Years | Vanderbilt University Medical Center | ||
| Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial | NCT04727307 | Hepatocellular ... | Atezolizumab (n... Percutaneous Ra... Bevacizumab (ad... Atezolizumab (a... | 18 Years - | University Hospital, Montpellier | |
| Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease | NCT00543777 | Liver Cancer | Magnetic Resona... 2-Point Dixon M... | - | M.D. Anderson Cancer Center | |
| "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". | NCT04690972 | Chronic Liver D... Liver Cancer Non-Alcoholic F... Non-Alcoholic S... Viral Hepatitis... Viral Hepatitis... Viral Hepatitis... | Blood sample du... Taking an addit... Blood sample du... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) | NCT01871545 | Hepatocellular ... HCC | Magnetic Resona... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System | NCT02312817 | Carcinoma, Hepa... Liver Neoplasms | Mailed Outreach... Mailed Outreach... | 21 Years - | University of Texas Southwestern Medical Center | |
| "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". | NCT04690972 | Chronic Liver D... Liver Cancer Non-Alcoholic F... Non-Alcoholic S... Viral Hepatitis... Viral Hepatitis... Viral Hepatitis... | Blood sample du... Taking an addit... Blood sample du... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy | NCT00627042 | Hepatocellular ... | Ramucirumab (IM... | 18 Years - | Eli Lilly and Company | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia | NCT03357978 | Ataxia Telangie... | bioelectrical i... blood draw transient elast... ataxia score Five-Times-Sit-... | 2 Years - 45 Years | Johann Wolfgang Goethe University Hospital | |
| "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". | NCT04690972 | Chronic Liver D... Liver Cancer Non-Alcoholic F... Non-Alcoholic S... Viral Hepatitis... Viral Hepatitis... Viral Hepatitis... | Blood sample du... Taking an addit... Blood sample du... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System | NCT02312817 | Carcinoma, Hepa... Liver Neoplasms | Mailed Outreach... Mailed Outreach... | 21 Years - | University of Texas Southwestern Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
